Vicapsys Life Sciences, Inc. (OTCMKTS:VICP – Get Free Report)’s stock price traded down 36.1% during mid-day trading on Wednesday . The company traded as low as $0.62 and last traded at $0.62. 107 shares traded hands during mid-day trading, a decline of 40% from the average session volume of 179 shares. The stock had previously closed at $0.97.
Vicapsys Life Sciences Price Performance
The stock has a 50 day simple moving average of $1.75 and a 200-day simple moving average of $2.20.
Vicapsys Life Sciences Company Profile
Vicapsys Life Sciences, Inc focuses on the development and commercialization of VICAPSYN, a proprietary product. The company's product is applied to transplantation therapies and related stem-cell applications in the transplantation field. It also develops VYBRIN, a product based on CXCL12 for prevention of post-surgical adhesions in abdominal surgery, coating of implantable medical devices and other implants to eliminate fibrosis, and wound healing with a focus on diabetic ulcers.
Read More
- Five stocks we like better than Vicapsys Life Sciences
- What is Short Interest? How to Use It
- Comprehensive Analysis of PayPal Stock
- Airline Stocks – Top Airline Stocks to Buy Now
- Intuitive Surgical Stock Can Trend Much Higher This YearÂ
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Receive News & Ratings for Vicapsys Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicapsys Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.